MSOS Stock analysis – The DEA Announcement & M&A Activity

The Eu­ro­pean Com­mis­sion made the rare de­ci­sion Mon­day not to adopt the neg­a­tive opin­ion of the Eu­ro­pean Med­i­cines Agency’s Com­mit­tee for Med­i­c­i­nal Prod­ucts for Hu­man

A week af­ter one obe­si­ty biotech, Car­mot Ther­a­peu­tics, backed out of its IPO plans in fa­vor of a $2.7 bil­lion sale to Roche, an­oth­er an­nounced